Consolidated Statement Of Comprehensive Income

Daito Pharmaceutical Co., Ltd. - Filing #7542348

Concept 2023-06-01 to
2023-08-31
2022-06-01 to
2022-08-31
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
663,000,000 JPY
926,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
118,000,000 JPY
210,000,000 JPY
Foreign currency translation adjustment
37,000,000 JPY
82,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-25,000,000 JPY
19,000,000 JPY
Other comprehensive income
130,000,000 JPY
312,000,000 JPY
Comprehensive income
793,000,000 JPY
1,238,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
804,000,000 JPY
1,235,000,000 JPY
Comprehensive income attributable to non-controlling interests
-10,000,000 JPY
2,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.